Teladoc Health Added AI Features to Solo Platform
Healthcare providers using Solo can now access ambient documentation and contactless vital sign monitoring.
Updated on Oct. 7, 2026 in Healthcare
Live Poll
Do you trust AI tools to improve the quality of your healthcare experience?
Teladoc Health integrated SoloVitals and SoloScribe AI tools into its enterprise-grade Solo platform to streamline clinical documentation and patient monitoring. The updates are designed to reduce administrative workloads across thousands of healthcare facilities.
Why it matters
These tools address the high overhead of manual medical record-keeping and diagnostic data collection. By automating documentation and vitals capture, the company aims to reduce technology fragmentation for clinical teams.
The Solo platform is currently installed in more than 15,000 care locations worldwide. While SoloScribe is now generally available, the SoloVitals feature remains in a limited private preview phase.
The players
Teladoc Health
A publicly traded virtual care company that provides telehealth services and remote monitoring technologies to health systems and employers.
The details
SoloScribe utilizes ambient AI to generate structured clinical notes, which are then templated and transferred directly into Electronic Health Records. SoloVitals employs remote photoplethysmography, a technique that measures facial skin color variations to calculate heart and respiration rates without physical contact. These features attempt to eliminate the friction between virtual care workflows and administrative requirements.
Timeline
Teladoc Health announced the new AI platform capabilities on October 7, 2026.
SoloVitals is expected to be released generally in December 2026.
Market Landscape
The integration of remote photoplethysmography marks an evolution in how virtual care platforms ingest patient diagnostic data. This development follows a broader industry trend of embedding ambient AI directly into EHR-integrated workflows to combat clinician burnout.
Operators should evaluate whether the administrative time savings from automated clinical notes justify potential software subscription updates. Managers should also monitor the December 2026 rollout of contactless vitals to determine if this hardware-free capability reduces the need for peripheral diagnostic equipment.
The takeaway
The move reflects a push toward 'invisible' diagnostic tools that require no physical interaction or extra equipment. Clinical administrators should monitor the accuracy of these automated vitals against current hardware standards before modifying existing device procurement strategies.
What happens next
Organizations currently using the Solo platform should prepare for the broader deployment of SoloVitals, which is slated for general release in December 2026.
Further reading
For more on industry shifts in clinical technology, see our Healthcare section.
More information
For further specifications on these features, visit the Teladoc Health enterprise solutions information.
Live Poll
Do you trust AI tools to improve the quality of your healthcare experience?
